A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy
Esophageal Cancer, Pain, Postoperative
About this trial
This is an interventional treatment trial for Esophageal Cancer focused on measuring esophageal cancer, transversus abdominis plane catheter, epidural, pain, postoperative
Eligibility Criteria
Inclusion Criteria:
- All adult individuals who undergo an esophagectomy with a minimally invasive approach of the chest at Swedish Medical Center-First Hill. These approaches include:
- 3 hole with R video-assisted thoracoscopic surgery (VATS)
- Ivor Lewis R VATS
- Transhiatal
Exclusion Criteria:
- Age <18
- Unable to consent
- Additional surgical procedures planned
- Patient with chronic pain on a daily regimen of narcotics
- Patients who remain intubated greater than 24 hours post operatively
- Non-English speaking
Sites / Locations
- Swedish Cancer Institute
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Transversus abdominis plane catheter
epidural
Transversus abdominis plane catheter (TAP) for pain control in esophagectomy operations. TAP group will have bilateral subcostal TAP catheters and single shot bilateral rectus sheath blocks placed at the end of the surgery, prior to emergence. Bilateral subcostal TAP catheters will be bolused with 20ml of .2% ropivacaine on each side and then infused with .2% ropivacaine at 10ml/ hr for 75 hours each. Rectus sheath blocks will be bilateral bolus 20ml of .2% ropivacaine.
Epidural pain control for pain control in esophagectomy operation. Patients randomize the TEP group will have bilateral TEP placed at T8-9 +/- one level based on patient anatomy. TEP will be bolused with 5ml of 1.5% lidocaine with epinephrine and then started on infusion of .0625% bupivacaine plus 4 mcg/ml fentanyl plus 2 mcg/ ml epinephrine at 6ml/hr with a range of 6-12 ml/hr, titrating to optimize patient comfort. Epidurals are placed before surgery start time.